PAGANINI, CLAUDIA
PAGANINI, CLAUDIA
Mostra
records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.01 secondi).
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks
2024-01-01 Paganini, C; Talamonti, M; Maffei, V; Di Raimondo, C; Bianchi, L; Galluzzo, M
Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study
2024-03-24 Paganini, C; Maffei, V; Vellucci, L; Talamonti, M; Petruzzellis, A; Le Pera, L; DI RAIMONDO, C; Bianchi, L; Galluzzo, M
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab
2024-01-01 Russo, F; Cioppa, V; Lazzeri, L; Milanesi, N; Galluzzo, M; D'Erme, Am; Schettini, N; Cocuroccia, B; Sordi, D; Panebianco, A; Talamonti, M; Paganini, C; De Pità, O; Giampetruzzi, Ar; Scaglione, Gl
Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks
2023-01-01 Galluzzo, M; Marcelli, L; Vellucci, L; Paganini, C; Maffei, V; Tofani, L; Belcastro, A; Bianchi, L; Talamonti, M
letter in response to the case report: “recalcitrant generalized granuloma annulare treated successfully with dupilumab”
2023-01-01 Paganini, C; Talamonti, M; Campione, E; Bianchi, L; Galluzzo, M
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks | Paganini, C; Talamonti, M; Maffei, V; Di Raimondo, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 24-mar-2024 | Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study | Paganini, C; Maffei, V; Vellucci, L; Talamonti, M; Petruzzellis, A; Le Pera, L; DI RAIMONDO, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2024 | Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab | Russo, F; Cioppa, V; Lazzeri, L; Milanesi, N; Galluzzo, M; D'Erme, Am; Schettini, N; Cocuroccia, B; Sordi, D; Panebianco, A; Talamonti, M; Paganini, C; De Pità, O; Giampetruzzi, Ar; Scaglione, Gl | Articolo su rivista | |
| 1-gen-2023 | Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks | Galluzzo, M; Marcelli, L; Vellucci, L; Paganini, C; Maffei, V; Tofani, L; Belcastro, A; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2023 | letter in response to the case report: “recalcitrant generalized granuloma annulare treated successfully with dupilumab” | Paganini, C; Talamonti, M; Campione, E; Bianchi, L; Galluzzo, M | Articolo su rivista |